The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens
Contact Dermatitis · 2024
DOI: 10.1111/cod.14439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2024. Verfasst von Fabrice Battais und 8 weiteren Autor:innen. Beteiligte Einrichtung: French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), Toxicology and Biomonitoring Division, Vandoeu…. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Chemical‐induced allergies at workplace represent a significant occupational health issue. These substances must be properly identified as sensitizers. In previous studies, an original model using mouse bone marrow‐derived dendritic cells (BMDC) was developed for this purpose.
Objectives
The aim of this study was to evaluate the predictive capacity of the BMDC model with a large panel of sensitizers (including pre‐ and pro‐haptens) and non‐sensitizers.
Methods
The readout from the BMDC model is based on expression levels of six phenotypic markers measured by flow cytometry.
Results
The results indicate that 29 of the 37 non‐sensitizers, and 81 of the 86 sensitizers were correctly classified compared to the Local Lymph Node Assay (LLNA). Statistical analysis revealed the BMDC model to have a sensitivity of 94%, a specificity of 78%, and an accuracy of 89%. The EC2 (Effective Concentration) values calculated with this model allow sensitizers to be categorized into four classes: extreme, strong, moderate and weak.
Conclusions
These excellent predictive performances show that the BMDC model discriminates between sensitizers and non‐sensitizers with outstanding precision equal to or better than existing validated alternative models. Moreover, this model allows to predict sensitization potency of chemicals. The BMDC test could therefore be proposed as an additional tool to assess the sensitizing potential and potency of chemicals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), Toxicology and Biomonitoring Division, Vandoeuvre les Nancy, France.
ORCID-Profile: Fabrice Battais, Mélanie Mourot-Bousquenaud
Zitieren
APA
Battais, F., Langonné, I., Muller, S., Mathiot, J., Coiscaud, A., Audry, A., Remy, A. M., Sponne, I., & Mourot-Bousquenaud, M. (2024). The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens. Contact Dermatitis. https://doi.org/10.1111/cod.14439
Vancouver
Battais F, Langonné I, Muller S, Mathiot J, Coiscaud A, Audry A, et al. The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens. Contact Dermatitis. 2024. doi:10.1111/cod.14439
BibTeX
@article{Battais2024,
author = {Battais, Fabrice and Langonné, Isabelle and Muller, Samuel and Mathiot, Julianne and Coiscaud, Amélie and Audry, Adrien and Remy, Aurélie Martin and Sponne, Isabelle and Mourot-Bousquenaud, Mélanie},
title = {The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14439}
}
EUVIMED